Stanley Rossman
Hematology & Oncology · van Nuys, CANPI 1578667127
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 266 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 266 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$702
- E.r. Squibb & Sons, L.L.C.$415
- Genentech USA, Inc.$352
- Takeda Pharmaceuticals U.S.A., Inc.$330
- Amgen$268
- Novartis$241
- plus $3K from 37 others
What the payments were for
- Food & beverage$5,21197%
- Education$1853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,396 in reported general payments places this provider in the 55th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in van Nuys
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.